PTGX icon

Protagonist Therapeutics

43 hedge funds and large institutions have $91.8M invested in Protagonist Therapeutics in 2017 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 11 reducing their positions, and 4 closing their positions.

Holders
43
Holders Change
+3
Holders Change %
+7.5%
% of All Funds
1.07%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
7
Increased
18
Reduced
11
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Morgan Stanley
26
Morgan Stanley
New York
$95K -$17.3K -1,524 -15%
New York State Common Retirement Fund
27
New York State Common Retirement Fund
New York
$86K -$11 -1 -0%
Wells Fargo
28
Wells Fargo
California
$67K +$8.21K +729 +14%
AIG
29
American International Group
New York
$66K +$14.2K +1,254 +27%
NFA
30
Nationwide Fund Advisors
Ohio
$49K
SO
31
STRS Ohio
Ohio
$27K
UBS Group
32
UBS Group
Switzerland
$19K +$15.3K +1,342 +408%
Manulife (Manufacturers Life Insurance)
33
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$13K -$71.3K -6,113 -85%
Legal & General Group
34
Legal & General Group
United Kingdom
$12K
BNP Paribas Financial Markets
35
BNP Paribas Financial Markets
France
$8.18K +$7.94K +702 +3,343%
AIP
36
Ameritas Investment Partners
Nebraska
$6K
Bank of Montreal
37
Bank of Montreal
Ontario, Canada
$6K +$6K +524 New
Barclays
38
Barclays
United Kingdom
$5K -$12.6K -1,171 -72%
Creative Planning
39
Creative Planning
Kansas
$2K
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
$1K -$3.67K -191 -79%
Citigroup
41
Citigroup
New York
$1K -$1.29K -81 -56%
MAM
42
Meeder Asset Management
Ohio
$1K +$316 +25 +46%
RCM
43
RA Capital Management
Massachusetts
-$8.15M -636,248 Closed
FCMI
44
Foresite Capital Management III
California
-$4.44M -346,281 Closed
SIM
45
Spark Investment Management
New York
-$403K -31,500 Closed
TRCT
46
Tower Research Capital (TRC)
New York
-$9K -656 Closed